Cargando…
Targeting MICA/B with cytotoxic therapeutic antibodies leads to tumor control
Background: MICA and MICB are tightly regulated stress-induced proteins that trigger the immune system by binding to the activating receptor NKG2D on cytotoxic lymphocytes. MICA and MICB are highly polymorphic molecules with prevalent expression on several types of solid tumors and limited expressio...
Autores principales: | Bléry, Mathieu, Mrabet-Kraiem, Manel, Morel, Ariane, Lhospice, Florence, Bregeon, Delphine, Bonnafous, Cécile, Gauthier, Laurent, Rossi, Benjamin, Remark, Romain, Cornen, Stéphanie, Anceriz, Nadia, Viaud, Nicolas, Trichard, Sylvia, Carpentier, Sabrina, Joulin-Giet, Alix, Grondin, Gwendoline, Liptakova, Veronika, Kim, Younghoon, Daniel, Laurent, Haffner, Aurélie, Macagno, Nicolas, Pouyet, Laurent, Perrot, Ivan, Paturel, Carine, Morel, Yannis, Steinle, Alexander, Romagné, François, Narni-Mancinelli, Emilie, Vivier, Eric |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7613279/ https://www.ncbi.nlm.nih.gov/pubmed/35967081 http://dx.doi.org/10.12688/openreseurope.13314.2 |
Ejemplares similares
-
Targeting MICA with therapeutic antibodies for the treatment of cancer
por: Bonnafous, Cécile, et al.
Publicado: (2013) -
Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model
por: Sola, Caroline, et al.
Publicado: (2013) -
S258: IPH6501 IS A FIRST-IN-CLASS TETRASPECIFIC ANTIBODY-BASED NATURAL KILLER CELL ENGAGER THERAPEUTIC DEVELOPED FOR THE TREATMENT OF B-CELL NON-HODGKIN’S LYMPHOMAS
por: Demaria, Olivier, et al.
Publicado: (2023) -
Novel therapeutic and diagnostic antibodies against KIR3DL2, a unique tumor antigen overexpressed on subtypes of T cell lymphomas
por: Marie-Cardine, Anne, et al.
Publicado: (2013) -
Anti-NKG2A mAb Is a Checkpoint Inhibitor that Promotes Anti-tumor Immunity by Unleashing Both T and NK Cells
por: André, Pascale, et al.
Publicado: (2018)